key articles
Guidelines for development of diagnostic markers in bladder cancer
Tuesday, 8 April 2008 - Advances in understanding cancer at the molecular level have identified numerous alterations associated with cancer development and progression. The efforts in evaluating these putative biomarkers in...
Authors: Goebell et al.
Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer
Thursday, 3 April 2008 - Hutterer et al. (2008) assessed the value of nuclear matrix protein-22 (NMP22), compared with urinary cytology, in predicting the recurrence of bladder cancer that is not transitional cell carcinoma...
Authors: Hutterer et al.
Meat intake and bladder cancer in a prospective study: a role for heterocyclic aromatic amines?
Wednesday, 2 April 2008 - The suspect carcinogens, heterocyclic amines (HAAs), found in well-done meat require host-mediated metabolic activation before inducing DNA mutations. The role of SULT1A1 (a human gene) and of NAT2 (also...
Authors: Lumbreras et al.
Perioperative chemotherapy could be a new strategy for bladder preservation
Friday, 28 March 2008 - New insights in bladder cancer were presented by Cora Sternberg, MD, from Rome during today’s meet-the-expert session on oncology. Perioperative chemotherapy in muscle-invasive bladder cancer possibly...
By Franz-Guenter Runkel
The clinical significance of micro-metastatic lymph node disease in kidney and bladder cancer
Thursday, 27 March 2008 - MILAN - Treatment failure in bladder and kidney cancer following definitive surgery with curative intent is one of the most important urological problems unsolved so far. In his today's state-of-the-art...
By: Franz-Guenter Runkel
Laparoscopic radical cystectomy and extracorporeal urinary diversion
Thursday, 20 March 2008 - Laparoscopic radical cystectoprostatectomy (LRC) with different urinary diversion. Methods has shown its benefits including decreased blood loss, decreased postoperative pain, better cosmesis, and an...
Authors: Hemal et al.
Outcome of patients refusing cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer
Friday, 14 March 2008 - Herr (2007) determined the outcome of patients who refuse cystectomy after receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer.Between 1995 and 2001, 63 patients were evaluated who...
Author: Herr
Comparison of three schedules of intravesical epirubicin in patients with non-muscle-invasive bladder cancer
Wednesday, 12 March 2008 - Hendricksen et al. (2007) studied the additive effect of either an early instillation or maintenance instillations of adjuvant intravesical epirubicin, as compared to the epirubicin "standard"...
Authors: Hendricksen et al.
Total and free prostate-specific-antigen kinetics in patients without prostate cancer undergoing radical cystoprostatectomy
Monday, 10 March 2008 - Radical cystoprostatectomy and radical prostatectomy are the two major operations to remove prostate totally and radically. Radical cystoprostatectomy is usually performed in patients with invasive bladder...
Authors: Gregorakis et al.
Outcome after radical cystectomy with limited or extended pelvic lymph node dissection
Friday, 7 March 2008 - Radical cystectomy is the standard treatment for muscle invasive bladder cancer Bilateral pelvic lymph node dissection (PLND) is a part of radical cystectomy to enhance local disease control and to improve...
Authors: Dhar et al.
